These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9698880)

  • 1. Quantitation of HIV-1 RNA viral load using nucleic acid sequence based amplification methodology and comparison with other surrogate markers for disease progression.
    Sitnik R; Pinho JR
    Mem Inst Oswaldo Cruz; 1998; 93(3):411-5. PubMed ID: 9698880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test.
    Vandamme AM; Schmit JC; Van Dooren S; Van Laethem K; Gobbers E; Kok W; Goubau P; Witvrouw M; Peetermans W; De Clercq E; Desmyter J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Oct; 13(2):127-39. PubMed ID: 8862277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR.
    Vandamme AM; Van Dooren S; Kok W; Goubau P; Fransen K; Kievits T; Schmit JC; De Clercq E; Desmyter J
    J Virol Methods; 1995 Mar; 52(1-2):121-32. PubMed ID: 7769025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Coste J; Montes B; Reynes J; Peeters M; Segarra C; Vendrell JP; Delaporte E; Segondy M
    J Med Virol; 1996 Dec; 50(4):293-302. PubMed ID: 8950685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.
    Mellors JW; Muñoz A; Giorgi JV; Margolick JB; Tassoni CJ; Gupta P; Kingsley LA; Todd JA; Saah AJ; Detels R; Phair JP; Rinaldo CR
    Ann Intern Med; 1997 Jun; 126(12):946-54. PubMed ID: 9182471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between plasma HIV-1 RNA levels and the rate of immunologic decline.
    Iuliano R; Forastieri G; Brizzi M; Mecocci L; Mazzotta F; Ceccherini-Nelli L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Apr; 14(5):408-14. PubMed ID: 9170414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma.
    Cao Y; Ho DD; Todd J; Kokka R; Urdea M; Lifson JD; Piatak M; Chen S; Hahn BH; Saag MS
    AIDS Res Hum Retroviruses; 1995 Mar; 11(3):353-61. PubMed ID: 7786581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement.
    Ledergerber B; Flepp M; Böni J; Tomasik Z; Cone RW; Lüthy R; Schüpbach J
    J Infect Dis; 2000 Apr; 181(4):1280-8. PubMed ID: 10751136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected persons.
    Bruisten SM; Frissen PH; Van Swieten P; Harrigan PR; Kinghorn I; Larder B; Weigel HM; De Vries E; Regez RM; Henrichs JH; Koot M; Huisman JG
    AIDS Res Hum Retroviruses; 1997 Mar; 13(4):327-35. PubMed ID: 9071432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa.
    Stevens G; Rekhviashvili N; Scott LE; Gonin R; Stevens W
    J Clin Microbiol; 2005 Feb; 43(2):857-61. PubMed ID: 15695692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen.
    Barletta JM; Edelman DC; Constantine NT
    Am J Clin Pathol; 2004 Jul; 122(1):20-7. PubMed ID: 15272526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy.
    Siller L; Martin NL; Kostuchenko P; Beckett L; Rautonen J; Cheng SC; Wara DW
    AIDS; 1993 Mar; 7(3):369-73. PubMed ID: 8097095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia.
    Sabin CA; Lepri AC; Devereux H; Phillips AN; Loveday C; Lee CA
    J Infect Dis; 2001 Aug; 184(4):511-4. PubMed ID: 11471111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].
    Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T; Lecha N; Rubio Rivas C
    An Med Interna; 2000 Oct; 17(10):533-7. PubMed ID: 11109648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection.
    van Gemen B; Kievits T; Schukkink R; van Strijp D; Malek LT; Sooknanan R; Huisman HG; Lens P
    J Virol Methods; 1993 Jul; 43(2):177-87. PubMed ID: 8366168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid plasma virus and CD4+ T-cell turnover in HIV-1 infection: evidence for an only transient interruption by treatment.
    Stellbrink HJ; Zöller B; Fenner T; Lichtenberg G; van Lunzen J; Albrecht H; Thiele HG; Greten H
    AIDS; 1996 Jul; 10(8):849-57. PubMed ID: 8828742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes.
    Gobbers E; Fransen K; Oosterlaken T; Janssens W; Heyndrickx L; Ivens T; Vereecken K; Schoones R; van de Wiel P; van der Groen G
    J Virol Methods; 1997 Jul; 66(2):293-301. PubMed ID: 9255740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings.
    Respess RA; Cachafeiro A; Withum D; Fiscus SA; Newman D; Branson B; Varnier OE; Lewis K; Dondero TJ
    J Clin Microbiol; 2005 Jan; 43(1):506-8. PubMed ID: 15635029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.